Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses

被引：48

作者：

Tretyakova, Irina ^{[1
]}

Pearce, Melissa B. ^{[2
]}

Florese, Ruth ^{[1
]}

Tumpey, Terrence M. ^{[2
]}

Pushko, Peter ^{[1
]}

机构：

[1] Medigen Inc, Frederick, MD USA

[2] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA

来源：

VIROLOGY | 2013年 / 442卷 / 01期

关键词：

Influenza; Virus-like particle; VLP; Vaccine; Trivalent; Avian influenza; PANDEMIC INFLUENZA; INFECTION; RESPONSES; MICE; SUSCEPTIBILITY; REPLICATION; ANTIBODIES; CANDIDATE; EFFICACY; ADULT;

D O I：

10.1016/j.virol.2013.03.027

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Avian influenza H5, H7 and H9 viruses top the World Health Organization's (WHO) list of subtypes with the greatest pandemic potential. Here we describe a recombinant virus-like particle (VLP) that co-localizes hemagglutinin (HA) proteins derived from H5N1, H7N2, and H9N2 viruses as an experimental vaccine against these viruses. A baculovirus vector was configured to co-express the H5, H7, and H9 genes from A/Viet Nam/1203/2004 (H5N1), A/New York/107/2003 (H7N2) and A/Hong Kong/33982/2009 (H9N2) viruses, respectively, as well as neuraminidase (NA) and matrix (M1) genes from A/Puerto Rico/8/1934 (H1N1) virus. Co-expression of these genes in Sf9 cells resulted in production of triple-subtype VLPs containing HA molecules derived from the three influenza viruses. The triple-subtype VLPs exhibited hemagglutination and neuraminidase activities and morphologically resembled influenza virions. Intranasal vaccination of ferrets with the VLPs resulted in induction of serum antibody responses and efficient protection against experimental challenges with H5N1, H7N2, and H9N2 viruses. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：67 / 73

页数：7

共 51 条

[1] Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility [J].